Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFXl-assisted Ingenol Mebutate for BCC
NCT03569345Phase 2Completed
- Start
- Nov 2017
- Primary completion
- May 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ingenol mebutate in basal cell carcinoma (BCC). Started Nov 2017; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT03569345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03569345.